Aethlon Medical Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 14, 2024, serves as a current report for Aethlon Medical, Inc., a Nevada corporation. The filing primarily discloses the Company's financial results for the quarter ended June 30, 2024, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release (Exhibit 99.1) incorporated by reference, but the text of that exhibit is not included in the source data.
Material Changes
No specific material changes versus the prior comparable period are quantified in the provided text. The filing indicates that the Company issued a press release regarding its Q2 2024 results, but the specific variances are not listed in the 8-K body.
Guidance, Outlook, and Risks
The filing includes a standard Regulation FD disclosure stating that the information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It explicitly states that this information shall not be incorporated by reference into other filings unless expressly set forth. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain specific Q2 2024 financial figures.
- Verify the Company's cash position and runway given the lack of specific liquidity data in this summary.
- Confirm the status of the Interim Chief Executive Officer and Chief Financial Officer, James B. Frakes, and any ongoing leadership transitions.
- Check for any subsequent filings that may incorporate the Q2 2024 results by reference.